MDLN Stock — Medline Inc.

Medline Inc. (MDLN)

Updated October 16, 2026.

MDLN is a Stock. Total return is -12.3% over the past 0.8 years, 27.2 points behind SPY at 14.9%.

Medline Inc. manufactures and distributes medical-surgical products and supplies serving hospitals, surgery centers, physician offices, and other healthcare facilities across the United States and internationally. The company operates through its Medline Brand segment, which produces surgical solutions, front-line care products like wound care and infection control supplies, and laboratory and diagnostic equipment, as well as a Supply Chain Solutions segment that procures third-party products and provides logistics and optimization services. The company does not currently have an established distribution schedule.

MDLN performance versus SPY

Price and return data through 2026-10-16.

Total return is -12.3% over the past 0.8 years, 27.2 points behind SPY at 14.9%. Its deepest 1-year drawdown was 36.7%.

MDLN key facts

Asset type

Stock

Asset class

Equity

Inception date

12/17/2025

Distribution frequency

None

Last close

$35.96 (as of 2026-10-16)

Market cap

$31,549,549,799

Average volume

7078938.0

Payout ratio

0.0%

P/E ratio

89.9

Forward P/E

20.9205

EPS

$0.40

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MDLN risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 36.7%.

Who may consider MDLN — and who may not

It is a weaker fit for investors who need monthly cash flow (MDLN does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on MDLN

• All tickers starting with M

Tagged: Healthcare.

Frequently asked questions